3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Rectal Neoplasms
10
Colonic Neoplasms
10
Stomach Neoplasms
8
Adenocarcinoma Of Esophagus
8
Pancreatic Neoplasms
7
Esophageal Neoplasms
7
Adenocarcinoma
6
Lymphoma, Large B-Cell, Diffuse
5
Cholangiocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasm Metastasis
4
Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Carcinoma
3
Biliary Tract Neoplasms
3
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumors
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Recurrence
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.